Aug. 11 at 4:10 AM
$CAW $BCRX $PYPL $ARDX $HROW CAW remains highly speculative, BioCryst advances rare-disease therapies, PayPal continues focusing on payment growth and efficiency, Ardelyx advances kidney-disease treatments, and Harrow benefits from ophthalmology demand. I'm watching liquidity, clinical milestones, transaction volumes, prescription growth, and healthcare demand.